According to a new report North America Vascular Graft Market, published by KBV research, the North America Vascular Graft Market Size would witness market growth of 5.4% CAGR during the forecast period (2017-2023).
The US market held the largest share in the North America Vascular Graft Market by Country in 2016, and would continue to be a dominant market till 2023. Additionally, The Mexico market is expected to witness a CAGR of 7.2% during (2017-2023).
The Abdominal Aortic Aneurysm (AAA) market held the largest share in the North America Endovascular Aneurysm Repair Stent Grafts Market by Type in 2016, and would continue to be a dominant market till 2023. The Thoracic Aortic Aneurysm (TAA) market is expected to witness a CAGR of 6.4% during (2017-2023).
The Polytetrafluoroethylene (PTFE) market held the largest share in the Mexico Vascular Graft Market by Raw Material in 2016, and would continue to be a dominant market till 2023. The Polyurethane (PU) market is expected to witness a CAGR of 9.5% during (2017-2023).
Full Report: https://www.kbvresearch.com/north-america-vascular-graft-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key impacting factors of the North America Vascular Graft Market have been discussed in the report with the elaborated company profiles of B. Braun Melsungen AG, C. R. Bard, Inc., Cardinal Health Inc., Medtronic, Endologix Inc., Cook Medical Inc., LeMaitre Vascular, Inc., Terumo Corporation, W. L. Gore & Associates, Inc., and Getinge AB.
By Product
By Raw Material
By End User
By Geography
Companies Profiled
Related Reports:
Asia Pacific Vascular Graft Market